To Study The Effect Of Lavangadya Churna And Dhatri Nisha Churna In The Treatment Of Type 2 Diabetes Mellitus

A Open Randomised Controlled Clinical Trial Of Lavangadya Churna With Dhatri Nisha Churna In Management Of Madhumeh With Special Reference To Diabetes Mellitus Type II - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100003

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed patient with type II Diabetes Mellitus with hyperglycaemia on treatment one or two types of Oral Hypoglycemic Agent 2 Age 30 To 60 years irrespective of sex and socioeconomic status will be selected for study 3 Blood sugar level Fasting is more than 126 Miligram Per Decilitre and less than 200 Miligram Per Decilitre and post prandial blood sugar level more than 200 Miligram Per Decilitre And less than 300 Miligram Per decilitre with symptoms of Prameha like Prabhuta Mootrata Nocturia Trishna Kshudhadhikya Swedaadhikya Kara Pada Tala Daha Nidraadhikya 4 HbA1c 6.5 Percentage to 8 Percentage

Exclusion criteria

Exclusion criteria: 1 Newly diagnosed Diabetes Mellitus with or without on treatment OHA or Insulin 2 Diagnosed Diabetes Mellitus with on treatment more than two OHA 3 Fasting bsl is more than 200mg per dl and PP bsl is more than 300mg per dl 4 Known Case Of Insulin Dependent Diabetes Mellitus URINARY Tract Infection Ketoacidosis acute infection anywhere on body Gangrene retinopathy nephropathy Diabetic foot Gestational diabetes

Design outcomes

Primary

Measure	Time frame
Study The Effect OF Lavangadya Churna In Management Of Madhumeha With Special Reference To Diabetes Mellitus Type IITimepoint: Initial Assessment 0th Day Follow up on 30th 60th Day Final Assessment 90th Day	—

Secondary

Measure	Time frame
To compare the results of trial group with standard group To study Madhumeha and Prameha in detail according to Ayurveda To study Diabetes Mellitus in detail according to modern science To study Lavangadya Churna in detailTimepoint: Initial Assessment 0th Day Follow up on 30th 60th Day Final Assessment 90th Day	—

Countries

India

Contacts

Public ContactDr Abhinandan Patil

Lrp Ayurvedic Medical College And Hospital PG institute and Research Centre Sangli

drabhinandanpatil@gmail.com9890205000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026